BRIEF-Biocept reports Q1 loss per share $0.21
May 11, 2017 at 16:24 PM EDT
* Biocept inc- cash and cash equivalents were $14.0 million as of March 31, 2017, compared with $4.6 million as of December 31, 2016 Source text for Eikon: Further company coverage:
